Published in J Virol on August 01, 2003
Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the United States. J Clin Microbiol (2013) 4.05
Identification of a novel coronavirus in bats. J Virol (2005) 3.48
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio (2014) 2.50
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event. J Virol (2005) 2.35
Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci U S A (2005) 2.21
Comparison of porcine epidemic diarrhea viruses from Germany and the United States, 2014. Emerg Infect Dis (2015) 2.08
Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol (2006) 1.91
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog (2014) 1.69
Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. Proc Natl Acad Sci U S A (2011) 1.65
Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein. J Virol (2004) 1.62
Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol (2006) 1.59
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol (2004) 1.58
Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol (2008) 1.47
Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate. J Virol (2004) 1.44
Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein. J Virol (2005) 1.43
Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J (2005) 1.41
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol (2010) 1.40
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog (2008) 1.36
Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron cryomicroscopy. J Virol (2006) 1.34
Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathog (2012) 1.34
Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol (2006) 1.34
Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies. J Virol (2004) 1.32
Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication. J Virol (2007) 1.32
Isolation and characterization of a variant porcine epidemic diarrhea virus in China. Virol J (2012) 1.29
Synthesis and characterization of a native, oligomeric form of recombinant severe acute respiratory syndrome coronavirus spike glycoprotein. J Virol (2004) 1.27
Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J Virol (2007) 1.25
Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system. J Virol (2005) 1.21
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol (2005) 1.18
Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol (2009) 1.18
Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses (2012) 1.18
The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells. J Virol (2006) 1.17
Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol (2008) 1.16
Structure, function and evolution of the hemagglutinin-esterase proteins of corona- and toroviruses. Glycoconj J (2006) 1.16
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol (2005) 1.16
Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol (2013) 1.15
Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J Virol (2011) 1.14
Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus. Proc Natl Acad Sci U S A (2004) 1.12
Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. J Virol (2004) 1.12
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature (2016) 1.12
Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein. Proc Natl Acad Sci U S A (2004) 1.11
Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion. J Virol (2007) 1.10
Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis (2012) 1.09
Receptor recognition mechanisms of coronaviruses: a decade of structural studies. J Virol (2014) 1.09
Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain. J Virol (2004) 1.08
Inhibition of human coronavirus NL63 infection at early stages of the replication cycle. Antimicrob Agents Chemother (2006) 1.07
Dynamics of coronavirus replication-transcription complexes. J Virol (2009) 1.07
Human respiratory coronavirus OC43: genetic stability and neuroinvasion. J Virol (2004) 1.06
Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J Virol (2009) 1.05
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol (2010) 1.04
Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicity. J Virol (2011) 1.04
Porcine epidemic diarrhea: a review of current epidemiology and available vaccines. Clin Exp Vaccine Res (2015) 1.04
Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation. J Virol (2008) 1.03
Identification and characterization of genetically divergent members of the newly established family Mesoniviridae. J Virol (2013) 1.03
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. Virology (2007) 1.01
Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. BMC Microbiol (2006) 1.01
Proteolytic activation of the porcine epidemic diarrhea coronavirus spike fusion protein by trypsin in cell culture. J Virol (2014) 1.01
Pre-fusion structure of a human coronavirus spike protein. Nature (2016) 1.01
Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J (2009) 1.01
The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization. Virol J (2005) 1.00
Receptor recognition and cross-species infections of SARS coronavirus. Antiviral Res (2013) 1.00
Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol (2008) 0.99
Genomic RNA sequence of feline coronavirus strain FCoV C1Je. J Feline Med Surg (2007) 0.98
Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J Virol (2005) 0.97
The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells. J Virol (2004) 0.96
Coronavirus spike protein inhibits host cell translation by interaction with eIF3f. PLoS One (2008) 0.96
Molecular characterization and phylogenetic analysis of new variants of the porcine epidemic diarrhea virus in Gansu, China in 2012. Viruses (2013) 0.96
Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J Virol (2006) 0.95
Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J Virol (2005) 0.95
Palmitoylations on murine coronavirus spike proteins are essential for virion assembly and infectivity. J Virol (2006) 0.95
Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro. J Virol (2005) 0.94
Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein. J Gen Virol (2011) 0.94
Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms. J Virol (2013) 0.93
Mobility and interactions of coronavirus nonstructural protein 4. J Virol (2011) 0.93
Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway. J Virol (2007) 0.92
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res (2014) 0.92
Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination. PLoS One (2013) 0.91
Role of spike protein endodomains in regulating coronavirus entry. J Biol Chem (2009) 0.89
Genomic and epidemiological characteristics provide new insights into the phylogeographical and spatiotemporal spread of porcine epidemic diarrhea virus in Asia. J Clin Microbiol (2015) 0.89
Coronavirus spike glycoprotein, extended at the carboxy terminus with green fluorescent protein, is assembly competent. J Virol (2004) 0.89
Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). J Pharm Pharm Sci (2008) 0.89
Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus. J Virol (2006) 0.88
Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range. J Virol (2006) 0.88
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. Virus Res (2006) 0.88
Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape? Viruses (2012) 0.88
Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat Struct Mol Biol (2016) 0.87
Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter. J Virol (2006) 0.87
Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell. J Virol (2014) 0.86
Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide. J Virol (2006) 0.86
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem (1987) 59.79
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem (1989) 29.15
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Core structure of gp41 from the HIV envelope glycoprotein. Cell (1997) 16.18
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29
Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem (2001) 8.96
Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci U S A (1994) 8.48
A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol (1995) 7.30
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc Natl Acad Sci U S A (1992) 5.88
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol (2000) 5.71
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65
Capture of an early fusion-active conformation of HIV-1 gp41. Nat Struct Biol (1998) 5.62
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J Virol (1998) 4.48
Coiled coils in both intracellular vesicle and viral membrane fusion. Cell (1998) 4.26
Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell (1999) 4.17
N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. Proc Natl Acad Sci U S A (1999) 3.90
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J (1998) 3.77
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76
Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc Natl Acad Sci U S A (1991) 3.70
Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell (1998) 3.69
Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J Gen Virol (1990) 3.59
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J (1996) 3.33
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci U S A (1999) 3.23
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol (1995) 3.11
Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A (1996) 3.07
Coronavirus spike proteins in viral entry and pathogenesis. Virology (2001) 2.85
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology (1998) 2.61
Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A (2000) 2.58
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci U S A (1998) 2.46
The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (2001) 2.41
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci U S A (1999) 2.32
A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into the low-pH-induced conformation. Proc Natl Acad Sci U S A (1995) 2.24
The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J (1996) 2.21
Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J Gen Virol (1988) 2.21
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. Proc Natl Acad Sci U S A (2001) 2.20
Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol (1991) 2.16
Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07
Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology (1996) 1.95
Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J Virol (1993) 1.81
The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. J Struct Biol (1999) 1.76
Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc Natl Acad Sci U S A (1997) 1.61
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci U S A (1998) 1.58
Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology (1995) 1.54
Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology (1998) 1.48
Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. J Mol Biol (2000) 1.42
Receptor-induced conformational changes of murine coronavirus spike protein. J Virol (2002) 1.39
Conformational change of the coronavirus peplomer glycoprotein at pH 8.0 and 37 degrees C correlates with virus aggregation and virus-induced cell fusion. J Virol (1990) 1.37
Enhancement of the vaccinia virus/phage T7 RNA polymerase expression system using encephalomyocarditis virus 5'-untranslated region sequences. Gene (1991) 1.34
Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology (1997) 1.33
Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J Virol (2001) 1.32
Furin is involved in baculovirus envelope fusion protein activation. J Virol (2002) 1.32
A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol (1997) 1.30
Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology (1997) 1.24
Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors. J Biol Chem (2002) 1.23
Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J Gen Virol (1993) 1.22
Inhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120. J Virol (1993) 1.22
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19
The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J Virol (1995) 1.17
The trimer-of-hairpins motif in membrane fusion: Visna virus. Proc Natl Acad Sci U S A (2001) 1.13
The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J Virol (1998) 1.12
Comparison of the morphology of three coronaviruses. Arch Virol (1979) 1.03
The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells. Virology (1991) 1.02
Communication between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAM1b receptor. Virology (2002) 0.92
Biosynthesis and function of the coronavirus spike protein. Adv Exp Med Biol (1990) 0.90
Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein. Virology (1993) 0.89
Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein. Adv Exp Med Biol (2001) 0.89
Fibrinogen: a preliminary analysis of the amino acid sequences of the portion of the alpha, beta and gamma-chains postulated to form the interdomainal link between globular regions of the molecule. J Mol Biol (1978) 0.82
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem (2002) 4.40
Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe (2010) 2.75
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol (2005) 2.70
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem (2005) 2.36
Single-cell analysis of population context advances RNAi screening at multiple levels. Mol Syst Biol (2012) 2.13
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med (2002) 1.86
Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog (2011) 1.66
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus. Am J Respir Crit Care Med (2015) 1.65
Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol (2004) 1.62
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol (2004) 1.58
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol (2010) 1.55
Switching species tropism: an effective way to manipulate the feline coronavirus genome. J Virol (2003) 1.54
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J Virol (2008) 1.47
Qualitative and quantitative ultrastructural analysis of the membrane rearrangements induced by coronavirus. Cell Microbiol (2010) 1.43
Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation (2003) 1.43
Mouse hepatitis coronavirus replication induces host translational shutoff and mRNA decay, with concomitant formation of stress granules and processing bodies. Cell Microbiol (2007) 1.38
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol (2013) 1.37
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activation. PLoS Pathog (2008) 1.36
Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol (2009) 1.36
The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology (2010) 1.33
Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin. J Biol Chem (2010) 1.32
The anti-inflammatory mechanisms of Hsp70. Front Immunol (2012) 1.31
A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One (2010) 1.28
Molecular interactions in the assembly of coronaviruses. Adv Virus Res (2005) 1.27
Coxsackievirus mutants that can bypass host factor PI4KIIIβ and the need for high levels of PI4P lipids for replication. Cell Res (2012) 1.27
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol (2008) 1.23
Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol (2003) 1.22
Murine coronavirus with an extended host range uses heparan sulfate as an entry receptor. J Virol (2005) 1.18
Virulence of Newcastle disease virus: what is known so far? Vet Res (2011) 1.18
Structural protein requirements in equine arteritis virus assembly. J Virol (2004) 1.16
Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization. J Virol (2002) 1.15
Molecular mimicry between Helicobacter pylori antigens and H+, K+ --adenosine triphosphatase in human gastric autoimmunity. J Exp Med (2003) 1.14
Infectious bursal disease virus capsid protein VP3 interacts both with VP1, the RNA-dependent RNA polymerase, and with viral double-stranded RNA. J Virol (2002) 1.13
Carvacrol induces heat shock protein 60 and inhibits synthesis of flagellin in Escherichia coli O157:H7. Appl Environ Microbiol (2007) 1.13
Heat shock protein 60: specific binding of lipopolysaccharide. J Immunol (2005) 1.12
Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol (2008) 1.12
Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis. Proc Natl Acad Sci U S A (2012) 1.09
Spike protein fusion peptide and feline coronavirus virulence. Emerg Infect Dis (2012) 1.09
Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step. J Virol (2010) 1.09
Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses. J Virol (2013) 1.08
The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8. J Virol (2007) 1.07
Dynamics of coronavirus replication-transcription complexes. J Virol (2009) 1.07
Retracted Role of the SEL1L:LC3-I complex as an ERAD tuning receptor in the mammalian ER. Mol Cell (2012) 1.06
A case of mistaken identity: HSPs are no DAMPs but DAMPERs. Cell Stress Chaperones (2011) 1.06
IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS One (2009) 1.05
Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J Immunol (2005) 1.05
Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J Virol (2007) 1.04
Complete genome sequence and taxonomic position of anguillid herpesvirus 1. J Gen Virol (2009) 1.04
The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol (2010) 1.04
Cell stress induced HSP are targets of regulatory T cells: a role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Lett (2007) 1.02
Cryo-electron tomography of mouse hepatitis virus: Insights into the structure of the coronavirion. Proc Natl Acad Sci U S A (2009) 1.02
Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein. Virology (2005) 1.01
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology (2003) 1.00
Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg Infect Dis (2011) 0.99
Coronaviruses as vectors: stability of foreign gene expression. J Virol (2005) 0.99
Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci U S A (2012) 0.98
Visualizing coronavirus RNA synthesis in time by using click chemistry. J Virol (2012) 0.98
A novel heat-shock protein coinducer boosts stress protein Hsp70 to activate T cell regulation of inflammation in autoimmune arthritis. Arthritis Rheum (2010) 0.98
Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant. Emerg Infect Dis (2015) 0.98
Vaccinia virus-induced microtubule-dependent cellular rearrangements. Traffic (2006) 0.97
A mRNA PCR for the diagnosis of feline infectious peritonitis. J Virol Methods (2004) 0.97
Formation of disulfide-linked complexes between the three minor envelope glycoproteins (GP2b, GP3, and GP4) of equine arteritis virus. J Virol (2003) 0.97
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PLoS One (2013) 0.96
Characterization of two new structural glycoproteins, GP(3) and GP(4), of equine arteritis virus. J Virol (2002) 0.95
Hsp70 expression and induction as a readout for detection of immune modulatory components in food. Cell Stress Chaperones (2009) 0.95
Heat shock proteins are no DAMPs, rather 'DAMPERs'. Nat Rev Immunol (2011) 0.95
Evolution of the hemagglutinin protein of the new pandemic H1N1 influenza virus: maintaining optimal receptor binding by compensatory substitutions. J Virol (2013) 0.94
Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis. Arthritis Rheum (2008) 0.94
PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity. PLoS One (2011) 0.93
Mobility and interactions of coronavirus nonstructural protein 4. J Virol (2011) 0.93
Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin. J Virol (2012) 0.93
An autophagy-independent role for LC3 in equine arteritis virus replication. Autophagy (2012) 0.92
CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog (2012) 0.92